Beginning July 1, 2026, Centers for Medicare & Medicaid Services (CMS) will operate the Medicare GLP-1 Bridge, a short-term demonstration intended to provide eligible Medicare Part D beneficiaries with access to certain GLP-1 medications for weight management
Ipamorelin is a synthetic pentapeptide and agonist of the ghrelin or growth hormone secretagogue receptor pathway
Laura Davisson, medical weight management director at West Virginia University, said losing coverage for medications is a nightmare for patients
Further, since this was an observational study, causality cannot be assumed and, in fact, there might be inverse causality
It is not pulsatile
Any signs of worsening depression or suicidality should be immediately reported to the doctor prescribing Lexapro